Navigation Links
Carnegie Mellon's Christopher Bettinger Develops Edible Electronics for Medical Device Industry
Date:4/11/2013

PITTSBURGH, April 10, 2013 /PRNewswire/ -- It sounds futuristic, but today Carnegie Mellon University researchers are developing edible electronic devices that can be implanted in the body to improve patient care.

(Logo: http://photos.prnewswire.com/prnh/20020422/CMULOGO )

"We are creating electronically active medical devices that can be implanted in the body," said Christopher Bettinger , an assistant professor in the departments of Materials Science and Engineering and Biomedical Engineering at CMU. "The idea is for a patient to consume a pill that encapsulates the device."

Bettinger, along with Jay Whitacre , a professor of materials science and engineering, is creating edible power sources for medical devices that can be taken orally using materials found in the daily diet. 

"Our design involves flexible polymer electrodes and a sodium ion electrochemical cell, which allows us to fold the mechanism into an edible pill that encapsulates the device," Bettinger said.

CMU researchers report that the edible device could be programmed and deployed in the gastrointestinal tract or the small intestine depending upon packaging. Once the battery packaging is in place, Bettinger's team would activate the battery.

Bettinger reports that the battery could power biosensors to measure biomarkers or monitor gastric problems. The battery also could be used to stimulate damaged tissue or help in targeted drug delivery for certain types of cancer.

"There's so much out there we can do with this novel approach to medical devices," said Bettinger, a recipient of the National Academy of Sciences Award for Initiatives in Research for his innovative work on advanced materials for next-generation implanted medical devices.   

Bettinger has worked for more than a decade at the interface of materials science and biomedical engineering. Some of his innovative technologies include new synthetic materials that mimic the natural properties of soft tissue and biodegradable electronics that could usher in a new era of electronically active implants.  

For additional information about Bettinger, see www.materials.cmu.edu/people/bettinger.html

About Carnegie Mellon University: Carnegie Mellon (www.cmu.edu) is a private, internationally ranked research university with programs in areas ranging from science, technology and business, to public policy, the humanities and the arts. More than 12,000 students in the university's seven schools and colleges benefit from a small student-to-faculty ratio and an education characterized by its focus on creating and implementing solutions for real problems, interdisciplinary collaboration and innovation. A global university, Carnegie Mellon's main campus in the United States is in Pittsburgh, Pa. It has campuses in California's Silicon Valley and Qatar, and programs in Africa, Asia, Australia, Europe and Mexico. The university is in the midst of "Inspire Innovation: The Campaign for Carnegie Mellon University," which aims to build its endowment, support faculty, students and innovative research, and enhance the physical campus with equipment and facility improvements.

 


'/>"/>
SOURCE Carnegie Mellon University
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cohera Medical Named Winner of 2013 Carnegie Science Award
2. Carnegie Mellon University Biomedical Engineers Lead Collaborative Team Developing New Astro Surgery Tools for NASA Deep Space Missions
3. Parents Less Likely To Develop Colds, Carnegie Mellon Research Shows
4. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
5. Christopher Mennone Joins Surefire Medical Team As International Business Director
6. Zimmer Holdings Names Christopher Begley to Board of Directors
7. DART Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy
8. Rady Venture Fund Develops Next Generation Tech Investors
9. UK Laboratory Develops Amazing Fetal Ultrasound Image Technology
10. AnaptysBio Develops Novel Antibody Scaffold With Extreme Thermostability
11. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):